Expert opinions on prevention, screening, and active surveillance

There are three new and useful resources now available related to the prevention of prostate cancer, screening for prostate cancer, and the role of active surveillance in the expectant management of prostate cancer. … READ MORE …

Active surveillance among African-American males — some confusion

The appropriateness and utility of active surveillance as a management strategy for African-American men diagnosed with low-risk forms of prostate cancer appears to be becoming an issue of some mild controversy. … READ MORE …

MUSIC to the ears of advocates for active surveillance

A new paper from the coordinators of the Michigan Urological Surgery Improvement Collaborative (MUSIC) suggests that as many as 50 percent of newly diagnosed patients with low-risk forms of prostate cancer in Michigan are now receiving initial management on active surveillance (AS). … READ MORE …

Baseline data from the ProtecT trial … with outcomes still to come

Many readers of this blog will be interested to look through the data on the preliminary study design and diagnostic and baseline results of the randomized, phase III ProtecT trial that have just been reported in The Lancet Oncology. … READ MORE …

Data from two large cohorts of Austalian patients on active surveillance

A new paper in BJU International reports on data from a total of 650 Australian patients managed on active surveillance for low-risk, localized prostate cancer. … READ MORE …

Urologists recommend AS more often than rad/oncs (but probably not enough)

A new article on the Medscape web site, based on an article by Kim et al. in the journal Medical Care, deals with urologists’ and radiation oncologists’ recommendations for active surveillance (AS) as an appropriate form of treatment for low-risk prostate cancer in the USA today. … READ MORE …

How to mislead the public: a case study in apparent naivety

An article in today’s Daily Telegraph in the UK starts with the misleading statement that, “Up to half of men diagnosed with prostate cancer are being given ‘false hope’ by tests that are underestimating the severity of their disease, according to the authors of a new study.” … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,154 other followers